title: Reducing door-to-needle time for tPA use remains an elusive goal in stroke care.
authors.forename: Mike
authors.initials: M
authors.lastname: Mitka
mesh_terms: D000208:Acute Disease; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D019983:Guideline Adherence; D006761:Hospitals / Q000592:standards* / Q000706:statistics & numerical data; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014481:United States
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator